HC
GSK icon

HHG & Company’s GSK GSK Stock Holding History

HHG & Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,216
Closed -$474K – 136
2015
Q1 		$474K Buy
8,216
+90
+1% +$5.16K 0.12% 124
2014
Q4 		$434K Buy
8,126
+371
+5% +$20.8K 0.1% 139
2014
Q3 		$446K Buy
7,755
+99
+1% +$6.07K 0.15% 113
2014
Q2 		$509K Buy
7,656
+328
+4% +$22.2K 0.17% 125
2014
Q1 		$487K Buy
7,328
+512
+8% +$34.6K 0.17% 128
2013
Q4 		$453K Buy
6,816
+116
+2% +$7.52K 0.17% 125
2013
Q3 		$423K Hold
6,700
– – 0.17% 125
2013
Q2 		$415K Buy
+6,700
New +$425K 0.17% 126

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHG & Company's GSK Position: Q2 2015 in Review

HHG & Company sold out of GSK (GSK) in Q2 2015, closing a stake of 8,216 shares — an estimated $474K sold.

HHG & Company first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $509K in Q2 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • HHG & Company reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • HHG & Company sold 8,216 GSK shares in Q2 2015, an estimated $474K.
  • HHG & Company first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • HHG & Company's GSK position peaked at $509K in Q2 2014.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on HHG & Company's 13F filing for Q2 2015, filed 21 Jul 2015.